Center for Scientific Review; Notice of Closed Meetings, 27243-27244 [2013-10975]

Download as PDF 27243 Federal Register / Vol. 78, No. 90 / Thursday, May 9, 2013 / Notices prospective payment system, capitated rate, or other payment methodology. The updated Bulletin describes how exclusions can be violated and the administrative sanctions OIG can pursue against those who have violated an exclusion. The updated Bulletin also provides guidance to the health care industry on the scope and frequency of screening employees and contractors to determine whether they are excluded persons. OIG has posted the full revision of the Special Advisory Bulletin on its Web site: https://oig.hhs.gov/exclusions/ advisories.asp. FOR FURTHER INFORMATION CONTACT: Patrice S. Drew, Congressional and Regulatory Affairs, Office of Inspector General, (202) 619–1368. Daniel R. Levinson, Inspector General. [FR Doc. 2013–11055 Filed 5–8–13; 8:45 am] BILLING CODE 4152–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Proposed Collection; 60-Day Comment Request: Interactive Informed Consent for Pediatric Clinical Trials In compliance with the requirement of Section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, for opportunity for public comment on proposed data collection projects, the National Institute Heart, Lung, and Blood Institute (NHBLI), the National Institutes of Health (NIH) will publish periodic summaries of proposed SUMMARY: projects to be submitted to the Office of Management and Budget (OMB) for review and approval. Written comments and/or suggestions from the public and affected agencies are invited on one or more of the following points: (1) Whether the proposed collection of information is necessary for the proper performance of the function of the agency, including whether the information will have practical utility; (2) The accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; (3) Ways to enhance the quality, utility, and clarity of the information to be collected; and (4) Ways to minimize the burden of the collection of information on those who are to respond, including the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology. To Submit Comments and for Further Information: To obtain a copy of the data collection plans and instruments, submit comments in writing, or request more information on the proposed project, contact: Ms. Victoria Pemberton, Clinical Trials Specialist, National Heart, Lung, and Blood Institute, NIH, 6701 Rockledge Drive, Room 8102, MSC 7940, Bethesda, MD, or call non-toll-free number 301–435– 0510, or Email your request, including your address to: pembertonv@nhlbi.nih.gov. Formal requests for additional plans and instruments must be requested in writing. DATES: Comment Due Date: Comments regarding this information collection are Number of respondents Type of respondents Parents ............................................................................................................. Children ............................................................................................................ mstockstill on DSK4VPTVN1PROD with NOTICES DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2013–11034 Filed 5–8–13; 8:45 am] Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., VerDate Mar<15>2010 17:18 May 08, 2013 Jkt 229001 National Institutes of Health Center for Scientific Review; Notice of Closed Meetings PO 00000 Frm 00066 Fmt 4703 Sfmt 4703 Number of responses per response 148 136 Dated: April 29, 2013. Lynn Susulske, NHLBI Project Clearance Liaison, National Institutes of Health. Michael S. Lauer, Director, DCVS, National Institutes of Health. BILLING CODE 4140–01–P best assured of having their full effect if received within 60 days of the date of this publication. Proposed Collection: Interactive Informed Consent for Pediatric Clinical Trials, 0925-New, National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH). Need and Use of Information Collection: This study will compare parents’ and children’s understanding of information about a hypothetical clinical trial presented using either a standard paper consent document or an interactive computer-based consent program. Parents’ and children’s understanding, regardless of whether they received the standard consent or the interactive computer-based program, will be assessed by face-to-face interview. In addition, parents’ and children’s perceptions of, and satisfaction with, the information presented will be evaluated by completion of a short questionnaire. The primary hypothesis to be tested is that interactive computer-based research consent information is better understood and accepted by parents and children compared with the standard paper consent document. Given that many individuals have difficulty reading and interpreting standard written consent documents, this technology holds promise as a means to optimize the consent and assent process particularly among individuals with low literacy and numeracy skills. OMB approval is requested for 18 months. There are no costs to respondents other than their time. The total estimated annualized burden hours are 201. 1 1 Average burden per response (in hour) 40/60 45/60 Total annual burden hours 99 102 as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; RFA Panel: Systems Science and Health in the Behavioral and Social Sciences. Date: June 6, 2013. Time: 8:00 a.m. to 5:00 p.m. E:\FR\FM\09MYN1.SGM 09MYN1 mstockstill on DSK4VPTVN1PROD with NOTICES 27244 Federal Register / Vol. 78, No. 90 / Thursday, May 9, 2013 / Notices Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). Contact Person: Tomas Drgon, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3152, MSC 7770, Bethesda, MD 20892, 301–435– 1017, tdrgon@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Behavioral Science. Date: June 6, 2013. Time: 1:00 p.m. to 2:00 p.m. Agenda: To review and evaluate grant applications. Place: Washington Plaza Hotel, 10 Thomas Circle NW., Washington, DC 20005. Contact Person: Christine L Melchior, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5176, MSC 7844, Bethesda, MD 20892, (301) 435– 1713, melchioc@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR–11– 216: Early Phase Clinical Trials in Imaging and Image-Guided Interventions. Date: June 6, 2013. Time: 12:00 p.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Seattle Airport Marriott, 3201 S 176th Street, Seattle, WA 98188. Contact Person: David L Williams, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5110, MSC 7854, Bethesda, MD 20892, (301)435– 1174, williamsdl2@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR–12– 140: Role of the Microflora in the Etiology of Gastro-Intestinal Cancer. Date: June 6, 2013. Time: 12:00 p.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Ryan G Morris, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4205, MSC 7814, Bethesda, MD 20892, 301–435– 1501, morrisr@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; PAR–12– 140: Role of the Microflora in the Etiology of Gastro-Intestinal Cancer. Date: June 6, 2013. Time: 12:00 p.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). Contact Person: Peter J Perrin, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2180, MSC 7818, Bethesda, MD 20892, (301) 435– 0682, perrinp@csr.nih.gov. VerDate Mar<15>2010 17:18 May 08, 2013 Jkt 229001 Name of Committee: Center for Scientific Review Special Emphasis Panel; Translational and Basic Research to Control Itch in Humans. Date: June 6, 2013. Time: 12:00 p.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites—Chicago O’Hare— Rosemont, 5500 N. River Road, Rosemont, IL 60018. Contact Person: Aftab A Ansari, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4108, MSC 7814, Bethesda, MD 20892, 301–237– 9931, ansaria@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Pathophysiology and Clinical Studies of Osteonecrosis of the Jaw. Date: June 7, 2013. Time: 11:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Yi-Hsin Liu, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4214, MSC 7814, Bethesda, MD 20892, 301–435– 1781, liuyh@csr.nih.gov. Name of Committee: Center for Scientific Review Special Emphasis Panel; Statistical Genetics Supplements. Date: June 7, 2013. Time: 11:30 a.m. to 12:30 p.m. Agenda: To review and evaluate grant applications. Place: Beacon Hotel and Corporate Quarters, 1615 Rhode Island Avenue NW., Washington, DC 20036. Contact Person: Barbara J Thomas, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 2218, MSC 7890, Bethesda, MD 20892, 301–435– 0603, bthomas@csr.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393–93.396, 93.837–93.844, 93.846–93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: May 3, 2013. Michelle Trout, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2013–10975 Filed 5–8–13; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as PO 00000 Frm 00067 Fmt 4703 Sfmt 4703 amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Vascular and Hematology Integrated Review Group; Vascular Cell and Molecular Biology Study Section. Date: June 3–4, 2013. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road NW., Washington, DC 20015. Contact Person: Larry Pinkus, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4132, MSC 7802, Bethesda, MD 20892, (301) 435– 1214, pinkusl@csr.nih.gov. Name of Committee: Surgical Sciences, Biomedical Imaging and Bioengineering Integrated Review Group; Biomedical Imaging Technology A Study Section, Date: June 6–7, 2013. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Seattle Airport Marriott, 3201 South 176th Street, Seattle, WA 98188. Contact Person: Behrouz Shabestari, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5126, MSC 7854, Bethesda, MD 20892, (301) 435– 2409, shabestb@csr.nih.gov. Name of Committee: Biological Chemistry and Macromolecular Biophysics Integrated Review Group; Macromolecular Structure and Function B Study Section. Date: June 6, 2013. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Arnold Revzin, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4146, MSC 7824, Bethesda, MD 20892, (301) 435– 1153, revzina@csr.nih.gov. Name of Committee: Cell Biology Integrated Review Group; Intercellular Interactions Study Section. Date: June 6, 2013. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Warwick Seattle Hotel, 401 Lenora Street, Seattle, WA 98121. E:\FR\FM\09MYN1.SGM 09MYN1

Agencies

[Federal Register Volume 78, Number 90 (Thursday, May 9, 2013)]
[Notices]
[Pages 27243-27244]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2013-10975]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; RFA Panel: Systems Science and Health in the Behavioral and 
Social Sciences.
    Date: June 6, 2013.
    Time: 8:00 a.m. to 5:00 p.m.

[[Page 27244]]

    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Virtual Meeting).
    Contact Person: Tomas Drgon, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 3152, MSC 7770, Bethesda, MD 20892, 301-435-
1017, tdrgon@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Behavioral Science.
    Date: June 6, 2013.
    Time: 1:00 p.m. to 2:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Washington Plaza Hotel, 10 Thomas Circle NW., Washington, 
DC 20005.
    Contact Person: Christine L Melchior, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5176, MSC 7844, Bethesda, MD 
20892, (301) 435-1713, melchioc@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR-11-216: Early Phase Clinical Trials in Imaging and Image-
Guided Interventions.
    Date: June 6, 2013.
    Time: 12:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Seattle Airport Marriott, 3201 S 176th Street, Seattle, 
WA 98188.
    Contact Person: David L Williams, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 5110, MSC 7854, Bethesda, MD 
20892, (301)435-1174, williamsdl2@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR-12-140: Role of the Microflora in the Etiology of Gastro-
Intestinal Cancer.
    Date: June 6, 2013.
    Time: 12:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Ryan G Morris, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 4205, MSC 7814, Bethesda, MD 20892, 301-435-
1501, morrisr@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR-12-140: Role of the Microflora in the Etiology of Gastro-
Intestinal Cancer.
    Date: June 6, 2013.
    Time: 12:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892, (Telephone Conference Call).
    Contact Person: Peter J Perrin, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 2180, MSC 7818, Bethesda, MD 
20892, (301) 435-0682, perrinp@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Translational and Basic Research to Control Itch in Humans.
    Date: June 6, 2013.
    Time: 12:00 p.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Embassy Suites--Chicago O'Hare--Rosemont, 5500 N. River 
Road, Rosemont, IL 60018.
    Contact Person: Aftab A Ansari, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 4108, MSC 7814, Bethesda, MD 
20892, 301-237-9931, ansaria@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Pathophysiology and Clinical Studies of Osteonecrosis of the 
Jaw.
    Date: June 7, 2013.
    Time: 11:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 
Wisconsin Avenue, Bethesda, MD 20814.
    Contact Person: Yi-Hsin Liu, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 4214, MSC 7814, Bethesda, MD 20892, 301-435-
1781, liuyh@csr.nih.gov.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Statistical Genetics Supplements.
    Date: June 7, 2013.
    Time: 11:30 a.m. to 12:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Beacon Hotel and Corporate Quarters, 1615 Rhode Island 
Avenue NW., Washington, DC 20036.
    Contact Person: Barbara J Thomas, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 2218, MSC 7890, Bethesda, MD 
20892, 301-435-0603, bthomas@csr.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: May 3, 2013.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2013-10975 Filed 5-8-13; 8:45 am]
BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.